Anemia en la enfermedad inflamatoria intestinal: un objetivo subestimado

Translated title of the contribution: Anemia in inflammatory bowel disease

Rodrigo Quera*, Paulina Núñez, Lilian Flores

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Anemia is the most common extraintestinal manifestation of inflammatory bowel disease (IBD). Although there are several causes of anemia in IBD, the two most frequent etiologies are iron deficiency anemia and anemia of chronic disease. Despite the high prevalence of anemia in IBD and its significant impact on patient´s quality of life, this complication is still underdiagnosed and undertreated by providers. Active screening for anemia, structured assessment, comprehensive management, and multidisciplinary collaboration are needed in IBD patients. The cornerstone of anemia management depends on the underlying etiology along with normalization of inflammatory activity. Although, oral iron is effective for the treatment of mild iron deficiency-related anemia, intravenous iron formulations have a good safety profile and can be used as first-line therapy in patients with active IBD, severe anemia and previous intolerance prior to oral iron. After proper treatment of anemia, careful monitoring is necessary to prevent its recurrence. Herein, we discuss the etiology, screening, diagnosis, therapy selection, and follow-up for anemia in IBD.

Translated title of the contributionAnemia in inflammatory bowel disease
Original languageSpanish
Pages (from-to)1063-1074
Number of pages12
JournalRevista Medica de Chile
Issue number8
StatePublished - Aug 2022

Bibliographical note

Publisher Copyright:
© 2022 Sociedad Medica de Santiago. All rights reserved.


  • Anemia
  • Inflammatory Bowel Diseases
  • Iron Deficiencies
  • Quality of Health Care
  • Vitamin B12 Deficiency


Dive into the research topics of 'Anemia in inflammatory bowel disease: un objetivo subestimado'. Together they form a unique fingerprint.

Cite this